Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

J B Chemicals and Pharmaceuticals Ltd (JBCH)

BSE
Currency in INR
1,764.10
-16.40(-0.92%)
Closed
JBCH Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
1,747.751,790.00
52 wk Range
1,399.952,029.00
Key Statistics
Edit
Bid/Ask
1,764.10 / 1,774.35
Prev. Close
1,780.5
Open
1,776.3
Day's Range
1,747.75-1,790
52 wk Range
1,399.95-2,029
Volume
1.77K
Average Volume (3m)
3.94K
1-Year Change
21.26%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
JBCH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
2,173.77
Upside
+23.23%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
Show more

J B Chemicals and Pharmaceuticals Ltd Company Profile

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

Employees
5311
Market
India

Compare JBCH to Peers and Sector

Metrics to compare
JBCH
Peers
Sector
Relationship
P/E Ratio
44.8x39.0x−0.7x
PEG Ratio
1.830.770.00
Price/Book
8.5x6.2x2.6x
Price / LTM Sales
7.4x5.4x3.2x
Upside (Analyst Target)
26.4%9.1%46.6%
Fair Value Upside
Unlock−10.7%7.4%Unlock

Analysts' Recommendations

11 Buy
2 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2,173.77

(+23.22% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 39.39
Dividend Yield
0.69%
Industry Median 0.71%
Annualised payout
12.2500
Paid unevenly
5-Years Growth
-
Growth Streak

FAQ

What Is the J.B. Chemicals&Pharma (JBCH) Stock Price Today?

The J.B. Chemicals&Pharma stock price today is 1,764.10.

What Stock Exchange Does J.B. Chemicals&Pharma Trade On?

J.B. Chemicals&Pharma is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for J.B. Chemicals&Pharma?

The stock symbol for J.B. Chemicals&Pharma is "JBCH."

Does J.B. Chemicals&Pharma Pay Dividends? What’s The Current Dividend Yield?

The J B Chemicals and Pharmaceuticals Ltd dividend yield is 0.69%.

What Is the J.B. Chemicals&Pharma Market Cap?

As of today, J.B. Chemicals&Pharma market cap is 273.99B.

What is J.B. Chemicals&Pharma Earnings Per Share?

The J.B. Chemicals&Pharma EPS is 39.39.

What Is the Next J.B. Chemicals&Pharma Earnings Date?

J.B. Chemicals&Pharma will release its next earnings report on 10 Feb 2025.

From a Technical Analysis Perspective, Is JBCH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.